1. Home
  2. CNTB vs CATO Comparison

CNTB vs CATO Comparison

Compare CNTB & CATO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTB
  • CATO
  • Stock Information
  • Founded
  • CNTB 2012
  • CATO 1946
  • Country
  • CNTB United States
  • CATO United States
  • Employees
  • CNTB N/A
  • CATO N/A
  • Industry
  • CNTB Biotechnology: Pharmaceutical Preparations
  • CATO Clothing/Shoe/Accessory Stores
  • Sector
  • CNTB Health Care
  • CATO Consumer Discretionary
  • Exchange
  • CNTB Nasdaq
  • CATO Nasdaq
  • Market Cap
  • CNTB 90.3M
  • CATO 88.2M
  • IPO Year
  • CNTB 2021
  • CATO N/A
  • Fundamental
  • Price
  • CNTB N/A
  • CATO N/A
  • Analyst Decision
  • CNTB Strong Buy
  • CATO
  • Analyst Count
  • CNTB 2
  • CATO 0
  • Target Price
  • CNTB $7.50
  • CATO N/A
  • AVG Volume (30 Days)
  • CNTB 88.0K
  • CATO 47.1K
  • Earning Date
  • CNTB 11-13-2025
  • CATO 11-20-2025
  • Dividend Yield
  • CNTB N/A
  • CATO N/A
  • EPS Growth
  • CNTB N/A
  • CATO N/A
  • EPS
  • CNTB N/A
  • CATO N/A
  • Revenue
  • CNTB $1,965,000.00
  • CATO $650,830,000.00
  • Revenue This Year
  • CNTB N/A
  • CATO N/A
  • Revenue Next Year
  • CNTB $453,067.90
  • CATO N/A
  • P/E Ratio
  • CNTB N/A
  • CATO N/A
  • Revenue Growth
  • CNTB N/A
  • CATO N/A
  • 52 Week Low
  • CNTB $1.23
  • CATO $2.19
  • 52 Week High
  • CNTB $2.20
  • CATO $6.70
  • Technical
  • Relative Strength Index (RSI)
  • CNTB 58.99
  • CATO N/A
  • Support Level
  • CNTB $1.36
  • CATO N/A
  • Resistance Level
  • CNTB $1.88
  • CATO N/A
  • Average True Range (ATR)
  • CNTB 0.15
  • CATO 0.00
  • MACD
  • CNTB 0.04
  • CATO 0.00
  • Stochastic Oscillator
  • CNTB 99.48
  • CATO 0.00

About CNTB Connect Biopharma Holdings Limited

Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.

About CATO Cato Corporation (The)

The Cato Corp operates as a specialty retailer of fashion apparel and accessories in the southeastern United States. Its primary objective is to be the fashion specialty retailer for fashion and value in its markets. The company operates through the following business segments: Retail and Credit. The Retail segment which generates the majority of revenue offers fashion specialty stores. The Credit segment involves credit card services.

Share on Social Networks: